ARTICLE | Clinical News
CRXA positive Phase III data
January 8, 2002 8:00 AM UTC
In an after-market announcement, Corixa (CRXA) and partner Rhein Biotech (NMarkt:RBO) said preliminary data from 272 evaluable patients in a Phase III trial showed that significantly more patients wer...